Home
Photo of Therése Klingstedt

Therése Klingstedt

Principal Research Engineer

Publications

2024

Tobias Rautio, Robin Obrist, Lucas Krebs, Therése Klingstedt, Johan Dahlén, Xiongyu Wu, Henrik Green (2024) In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references Drug Testing and Analysis (Article in journal) Continue to DOI
Therése Klingstedt, Linda Lantz, Hamid Shirani, Junyue Ge, Jorg Hanrieder, Ruben Vidal, Bernardino Ghetti, Peter Nilsson (2024) Thiophene-Based Ligands for Specific Assignment of Distinct Aß Pathologies in Alzheimer's Disease ACS Chemical Neuroscience (Article in journal) Continue to DOI
Greta Elovsson, Therése Klingstedt, Mikaela Brown, Peter Nilsson, Ann-Christin Brorsson (2024) A Novel <i>Drosophila</i> Model of Alzheimer's Disease to Study Aß Proteotoxicity in the Digestive Tract International Journal of Molecular Sciences, Vol. 25, Article 2105 (Article in journal) Continue to DOI

2023

Linda Lantz, Hamid Shirani, Bernardino Ghetti, Ruben Vidal, Therése Klingstedt, Peter Nilsson (2023) Thiophene-Based Ligands for Histological Multiplex Spectral Detection of Distinct Protein Aggregates in Alzheimers Disease Chemistry - A European Journal, Vol. 29, Article e202203568 (Article in journal) Continue to DOI
Linnea Björk, Therése Klingstedt, Peter Nilsson (2023) Thiophene-Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic-Disease-Associated Protein Aggregates ChemBioChem, Vol. 24, Article e202300044 (Article, review/survey) Continue to DOI

News

Peter Nilsson.

Peter Nilsson’s molecules shine a light on Alzheimer’s research

“Even though I’m a professor now, I still spend a lot of time in the lab, as I know that when I’m working hands on, that’s when I get the new ideas,” says Peter Nilsson. He develops tracer molecules that are used in research into Alzheimer’s disease.
Microscopy image of protein aggregates stained green and red with the tracer molecules.

Tracer molecules can distinguish between very similar brain diseases

Two diseases that affect the brain, Parkinson’s disease and multiple system atrophy, show the same characteristics. Scientists have now shown that tracer molecules developed at LiU can distinguish between these diseases.

Tags